Interstitial lung diseases (ILDs) refer to a heterogeneous and complex group of conditions
characterized by inflammation, fibrosis, or both, in the interstitium of the lungs. This results in …

ABSTRACT Introduction Interstitial lung diseases (ILDs) are a heterogeneous group of
inflammatory and/or fibrotic conditions with variable outcome and often a dismal prognosis …

Background Patients with chronic respiratory diseases and those in the postdischarge
period following hospitalization because of COVID-19 are particularly vulnerable, and little is …

Background Opportunities for home-monitoring are increasing exponentially. Home-
spirometry is reproducible and reliable in interstitial lung disease (ILD), yet patients' …

Introduction Clinicians and policymakers are promoting widespread use of home technology
including spirometry to detect disease progression for patients with interstitial lung disease …

Progressive fibrosing interstitial lung diseases (PF-ILDs) represent a group of conditions of
both known and unknown origin which continue to worsen despite standard treatments …

Background Remote monitoring of patient-recorded spirometry and pulse oximetry offers an
alternative approach to traditional hospital-based monitoring of interstitial lung disease …

(1) Background: home-based spirometry, as a form of telemedicine in pulmonology, was
previously successfully implemented in clinical practice in developed countries. However …

Introduction Patients diagnosed with Interstitial Lung Diseases (ILD) use devices to self-
monitor their health and well-being. Little is known about the range of devices, selection …

Background and aims Predicting progression and prognosis in Interstitial Lung Diseases
(ILD), especially Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis …